🇺🇸 FDA
Patent

US 11806406

Virus-like particle conjugates for diagnosis and treatment of tumors

granted A61KA61K2039/545A61K2039/585

Quick answer

US patent 11806406 (Virus-like particle conjugates for diagnosis and treatment of tumors) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Nov 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/545, A61K2039/585, A61K39/12, A61K41/0057